NCT03506841View on ClinicalTrials.gov

Cerebrolysin and Neurodevelopment in Preterm Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Infant DevelopmentCerebral PalsyPreterm Infant
Interventions
DRUG

Cerebrolysin

Cerebrolysin injections of 0.1 mL/kg body weight for 3 months (total of twelve injections).

Trial Locations (1)

35111

Mansoura University Children Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Children Hospital

OTHER

NCT03506841 - Cerebrolysin and Neurodevelopment in Preterm Infants | Biotech Hunter | Biotech Hunter